Who invested in CymaBay Therapeutics?
CymaBay Therapeutics's investors include Bay City Capital, Venrock, Versant Ventures, Alta Partners and Birchmere Ventures, and 19 more on record.
United States · Funded startup
8 rounds we have observed, with the 24 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$172Mraised across 8 rounds since 2003, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $325K sold, first sale Aug 2015
Reported by bizjournals.comSEC filing: $30M sold, first sale Sept 2013
No investor was named in the report.
Reported by sec.govSEC filing: $27M sold, first sale Sept 2013
No investor was named in the report.
From a historical funding record
Reported by metabolex.com
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CymaBay Therapeutics's investors include Bay City Capital, Venrock, Versant Ventures, Alta Partners and Birchmere Ventures, and 19 more on record.
CymaBay Therapeutics has raised $172M across 8 rounds since 2003.
CymaBay Therapeutics's most recent round was a Debt of $325K in Aug 2015.
CymaBay Therapeutics's largest round on record is $44M (Series B), in Dec 2004.
CymaBay Therapeutics's first round on record, in Aug 2003, was backed by Bay City Capital, CDP Capital Technology Ventures and Charter Venture Group and 1 others.
CymaBay Therapeutics's latest named round is a Debt, in Aug 2015.
CymaBay Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.